4/A//SEC Filing
Kronauge James F 4/A
Accession 0001209191-09-026749
CIK 0001340752other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 6:40 PM ET
Size
10.4 KB
Accession
0001209191-09-026749
Insider Transaction Report
Form 4/AAmended
Kronauge James F
VP Process Chemistry
Transactions
- Award
Employee Stock Option (right to buy)
2009-05-12+40,000→ 40,000 totalExercise: $3.93Exp: 2019-05-12→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]This amendment to Form 4 is being filed to correct the vesting schedule for 25,000 option shares reported on Form 4 so that all 40,000 option shares granted on May 12, 2009 by the Issuer to the reporting person shall vest over two years.
- [F2]This option vests and becomes exercisable in two equal annual installments of 20,000 shares each on May 12, 2010 and May 12, 2011, respectively.
Documents
Issuer
Molecular Insight Pharmaceuticals, Inc.
CIK 0001340752
Entity typeother
Related Parties
1- filerCIK 0001388060
Filing Metadata
- Form type
- 4/A
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 6:40 PM ET
- Size
- 10.4 KB